Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 29;6(4):e03846.
doi: 10.1016/j.heliyon.2020.e03846. eCollection 2020 Apr.

Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer

Govind Soni  1 , Ketaki Kale  2 , Saritha Shetty  2 , M K Gupta  1 , Khushwant S Yadav  2
Affiliations
Review

Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer

Govind Soni et al. Heliyon. .

Abstract

Polymeric nanoparticles prepared using high pressure homogenizer (HPH) present some unique challenges during manufacturing which can be better understood by application of quality by design (QbD) approaches. The present review highlights the ways to identify the critical material attributes which includes the anticancer drugs, polymers, surfactants, solvent system and dispersion system. A comprehensive understanding of the critical processing parameters like pressure and number of cycles during the working of HPH used in putting forward the critical quality attributes such as size, shape, surface charge or droplet stabilization. Such QbD approach will involve development of an effective control strategy for would ensure safe encapsulation of anticancer drugs for successful product development. Proper addressing of the issues related to scaling-up would lead to successful commercialization of the nano-sized formulations loaded with anticancer drugs.

Keywords: Anticancer drugs; Cancer research; High pressure homogenizer; Nanomaterials; Nanotechnology; Oncology; Pharmaceutical science; Polymeric nanoparticles; QbD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Life cycle of QbD in product development using HPH.
Figure 2
Figure 2
Parameters to be selected for developing an anticancer Nano product for selecting a Drug and delivery systems.
Figure 3
Figure 3
Schematic illustration of a homogenization process (adapted from Ref. [31]).
Figure 4
Figure 4
Mapping of CMA and CPP to CQA in High-Pressure Homogenizer (HPH) for formulation of Polymeric Nanoparticles using Ishikawa Diagram.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Doran J., Ryan G. Does nanotechnology research generate an innovation premium over other types of research? Evidence from Ireland. Technol. Soc. 2019;59:101183.
    1. Mukherjee A., Bhattacharyya S. Biotechnology Business-Concept to Delivery. Springer; Cham: 2020. Nanotechnology in medicine; pp. 57–64. 2020.
    1. Soni G., Yadav K.S. Modeling, Methodologies and Tools for Molecular and Nano-Scale Communications. Springer; Cham: 2017. Communication of drug loaded nanogels with cancer cell receptors for targeted delivery; pp. 503–515.
    1. Utreja P., Verma S., Rahman M., Kumar L. Use of nanoparticles in medicine. Curr. Biochem. Eng. 2020;6(1):7–24.
    1. Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015;33(9):941. - PMC - PubMed

LinkOut - more resources